{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:42:55Z","timestamp":1789731775238,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcin.2025.07.038","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:35:02Z","timestamp":1760546102000},"page":"2614-2624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-7453","authenticated-orcid":false,"given":"Abdullah","family":"Al-Abcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9552-4012","authenticated-orcid":false,"given":"Ghasaq","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhannad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-7835","authenticated-orcid":false,"given":"Mahmoud","family":"Ismayl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.","family":"Killu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0971","authenticated-orcid":false,"given":"Konstantinos C.","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-0959","authenticated-orcid":false,"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jcin.2025.07.038_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.112.099606","article-title":"Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States","volume":"126","author":"Goldstein","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jcin.2025.07.038_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.jcin.2025.07.038_bib3","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2025.02.602","article-title":"US Renal Data System 2024 annual data report: epidemiology of kidney disease in the United States","volume":"85","author":"Johansen","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.jcin.2025.07.038_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis","volume":"40","author":"O\u2019Shaughnessy","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jcin.2025.07.038_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jcin.2025.07.038_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jcin.2025.07.038_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jcp.25.9.745","article-title":"A clinical and experimental study of platelet function in chronic renal failure","volume":"25","author":"Evans","year":"1972","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.jcin.2025.07.038_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jacc.2019.10.059","article-title":"Oral anticoagulation for patients with atrial fibrillation on long-term dialysis","volume":"75","author":"Kuno","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2025.07.038_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ndt\/gfaa216","article-title":"Bleeding risk of haemodialysis and peritoneal dialysis patients","volume":"36","author":"van Eck van der Sluijs","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"24","key":"10.1016\/j.jcin.2025.07.038_bib10","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2025.07.038_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.07.038_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carrev.2021.04.019","article-title":"Left atrial appendage closure versus oral anticoagulation in non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"36","author":"Al-Abcha","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"issue":"9","key":"10.1016\/j.jcin.2025.07.038_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.recesp.2018.12.008","article-title":"Left atrial appendage occlusion in hemodialysis patients: initial experience","volume":"72","author":"Cruz-Gonz\u00e1lez","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"5","key":"10.1016\/j.jcin.2025.07.038_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/aor.13603","article-title":"Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience","volume":"44","author":"Xipell","year":"2020","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.jcin.2025.07.038_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40620-020-00774-5","article-title":"Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis","volume":"34","author":"Genovesi","year":"2021","journal-title":"J Nephrol"},{"issue":"3","key":"10.1016\/j.jcin.2025.07.038_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/EDE.0b013e318289dedf","article-title":"Matching by propensity score in cohort studies with three treatment groups","volume":"24","author":"Rassen","year":"2013","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.jcin.2025.07.038_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2175","article-title":"Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"3","author":"Randhawa","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"15","key":"10.1016\/j.jcin.2025.07.038_bib18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jcin.2025.07.038_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A randomized controlled trial comparing apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jcin.2025.07.038_bib20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jcin.2025.07.038_bib21","first-page":"610","article-title":"Left atrial appendage closure in end-stage renal disease and hemodialysis: data from a German multicenter registry","volume":"101","author":"Fink","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.jcin.2025.07.038_bib22","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/ckj\/sfad221","article-title":"Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study","volume":"16","author":"Genovesi","year":"2023","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.jcin.2025.07.038_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12928-022-00904-9","article-title":"Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan","volume":"38","author":"Ueno","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"issue":"10","key":"10.1016\/j.jcin.2025.07.038_bib24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00392-023-02359-1","article-title":"Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"113","author":"Flores-Umanzor","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2025.07.038_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hrthm.2024.07.028","article-title":"Impact of early bleeding on long-term mortality after left atrial appendage occlusion","volume":"22","author":"Lo Russo","year":"2025","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.jcin.2025.07.038_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical outcomes at 1 year following transcatheter left atrial appendage occlusion in the United States","volume":"15","author":"Price Matthew","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jcin.2025.07.038_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/j.ajkd.2021.08.023","article-title":"Treatment effect of percutaneous coronary intervention in dialysis patients with ST-elevation myocardial infarction","volume":"79","author":"Kawsara","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1016\/j.jcin.2025.07.038_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.027001","article-title":"Percutaneous left atrial appendage occlusion in comparison to non-vitamin k antagonist oral anticoagulant among patients with atrial fibrillation","volume":"11","author":"Noseworthy","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"10.1016\/j.jcin.2025.07.038_bib29","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jcin.2025.07.038_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825022332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825022332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:43:18Z","timestamp":1786027398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825022332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1936879825022332"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.07.038","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}